Raleigh, NC – Noverant is pleased to announce that it has selected Sequence, Inc. as a major channel partner. Under the non-exclusive, long term agreement, Sequence will lead the sales, marketing and account management efforts in a number of markets, initially focused on pharmaceutical, biotech, and medical device industries.
Commenting on the major alliance, Dr. Frank Gozzo, president and CEO of Noverant stated, “Noverant has enjoyed 6 consecutive years of strategic growth and is now prepared to take our unique services to the next level through qualified channel partners. Sequence has highly-qualified subject matter experts who work on-site with diverse clients in the life science industry, and so the synergy of their consultants with our technology makes good business sense.”
Michael Putnam, president and CEO of Sequence stated, “With over 11 years of hands-on experience in the life science industry, we have a keen awareness of the operational needs of our clients. After careful due diligence, we selected Noverant for their proven technology, genuine customer-driven approach and unique ability to provide a highly-scalable, device-independent information, training and compliance management platform.
Sequence is a leader in providing quality and compliance consulting services to the Pharmaceutical, Biotech, and other regulated industries. For more information, visit www.sequencevalidation.com.
Noverant is a leader in web-based information, training and compliance management applications, serving regulated and training-intensive clients on six continents. For more information, visit www.noverant.com.